识别抑制细胞入侵和转移的小分子,由WASF3激活促进转移
Jeane Silva1,2, Nivin Omar3, Vinoth Sittaramane4
1The Georgia Cancer Center, 1410 Laney Walker Blvd., Augusta, GA 30912, Georgia.
Heliyon
|October 23, 2023
概括
研究人员确定了通过向WASF3基因来抑制癌症转移的小分子. 一种化合物NSC670283在体内抑制了转移而不会影响细胞增殖,从而提供了新的治疗途径.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 药理学 药理学是指药理学的学科.
背景情况:
- WASF3基因是癌细胞入侵和转移的关键驱动因素.
- 抑制WASF3功能是癌症治疗的潜在策略.
研究的目的:
- 为了确定可以抑制WASF3-介导癌症转移的小分子.
- 在临床前癌症模型中评估已识别化合物的疗效.
主要方法:
- 使用NCI多样性集VI库对WASF3监管口袋进行in silico对接研究.
- 在试管体内选致死化合物对癌细胞运动,迁移和入侵的影响.
- 在斑马鱼的体内转移试验和细胞试验中进行体内转移试验,以确认目标相互作用和机制.
主要成果:
- 他们确定了三种抑制癌细胞运动,迁移和入侵的小分子.
- 在体内,NSC670283显著抑制了转移,但没有影响细胞增殖.
- NSC670283显示与WASF3的物理相互作用和减少了活性蛋白聚合.
结论:
- 小分子,特别是NSC670283,可以有效地抑制WASF3驱动的癌症入侵和转移.
- 这项研究首次确定了一种向WASF3导向转移的小分子.
- 这些发现为开发新型抗转移疗法奠定了基础.
相关概念视频
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Canonical Wnt Signaling Pathway
8.8K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K


